Demant Total Assets 2012-2023 | WILYY
- Demant total assets for the quarter ending December 31, 2023 were $4.435B, a 16.04% increase year-over-year.
- Demant total assets for 2023 were $4.435B, a 4.91% increase from 2022.
- Demant total assets for 2022 were $4.228B, a 6.89% increase from 2021.
- Demant total assets for 2021 were $3.955B, a 17.74% increase from 2020.
Demant Annual Total Assets (Millions of US $) |
|
---|---|
2023 | $4,435 |
2022 | $4,228 |
2021 | $3,955 |
2020 | $3,359 |
2019 | $3,268 |
2018 | $2,841 |
2017 | $2,464 |
2016 | $2,310 |
2015 | $2,142 |
2014 | $0 |
2013 | $1,845 |
2012 | $1,517 |
2011 | $1,429 |
Demant Quarterly Total Assets (Millions of US $) |
|
---|---|
2023-12-31 | $4,435 |
2022-12-31 | $4,228 |
2022-06-30 | $3,909 |
2021-12-31 | $3,955 |
2021-06-30 | $3,822 |
2020-12-31 | $3,359 |
2020-06-30 | $3,259 |
2019-12-31 | $3,268 |
2019-06-30 | $3,126 |
2018-12-31 | $2,841 |
2018-06-30 | $2,758 |
2017-12-31 | $2,464 |
2017-06-30 | $2,379 |
2016-12-31 | $2,310 |
2016-06-30 | $2,270 |
2015-12-31 | $2,142 |
2014-06-30 | $1,972 |
2013-12-31 | $1,845 |
2013-06-30 | $1,725 |
2012-12-31 | $1,517 |
2012-06-30 | $1,402 |
2011-12-31 | $1,429 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $11.148B | $3.257B |
Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company's business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $193.473B | 25.11 |
Stryker (SYK) | United States | $133.123B | 33.06 |
Medtronic (MDT) | Ireland | $111.139B | 15.73 |
EssilorLuxottica (ESLOY) | France | $102.775B | 0.00 |
Boston Scientific (BSX) | United States | $99.865B | 33.14 |
Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
Haleon (HLN) | United Kingdom | $38.831B | 30.04 |
ResMed (RMD) | United States | $28.562B | 28.56 |
Terumo (TRUMY) | Japan | $27.589B | 38.84 |
Zimmer Biomet Holdings (ZBH) | United States | $26.224B | 16.91 |
Baxter (BAX) | United States | $21.095B | 15.39 |
Koninklijke Philips (PHG) | Netherlands | $18.610B | 14.84 |
Insulet (PODD) | United States | $11.574B | 60.85 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.401B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.711B | 28.93 |
BellRing Brands (BRBR) | United States | $7.779B | 41.82 |
Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Haemonetics (HAE) | United States | $4.146B | 21.20 |
Lantheus Holdings (LNTH) | United States | $4.027B | 10.40 |
Prestige Consumer Healthcare (PBH) | United States | $3.575B | 16.90 |
Envista Holdings (NVST) | United States | $3.561B | 13.57 |
Neogen (NEOG) | United States | $3.248B | 31.25 |
QuidelOrtho (QDEL) | United States | $3.142B | 11.41 |
Green Thumb Industries (GTBIF) | United States | $2.981B | 94.47 |
ICU Medical (ICUI) | United States | $2.433B | 18.32 |
TG Therapeutics (TGTX) | United States | $2.384B | 772.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.097B | 0.00 |
Owens & Minor (OMI) | United States | $2.036B | 19.54 |
Verano Holdings (VRNOF) | United States | $1.879B | 0.00 |
InMode (INMD) | Israel | $1.736B | 8.99 |
National Vision Holdings (EYE) | United States | $1.710B | 53.24 |
Agios Pharmaceuticals (AGIO) | United States | $1.633B | 0.00 |
AdaptHealth (AHCO) | United States | $1.499B | 11.28 |
LeMaitre Vascular (LMAT) | United States | $1.470B | 48.81 |
AtriCure (ATRC) | United States | $1.407B | 0.00 |
Warby Parker (WRBY) | United States | $1.254B | 0.00 |
MacroGenics (MGNX) | United States | $0.888B | 0.00 |
Quanterix (QTRX) | United States | $0.834B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.820B | 0.00 |
Evolus (EOLS) | United States | $0.803B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.706B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.702B | 15.18 |
Canopy Growth (CGC) | Canada | $0.659B | 0.00 |
Valneva SE (VALN) | France | $0.543B | 0.00 |
Jin Medical (ZJYL) | China | $0.527B | 0.00 |
PetIQ (PETQ) | United States | $0.524B | 19.55 |
TerrAscend (TSNDF) | Canada | $0.521B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.520B | 11.26 |
OraSure Technologies (OSUR) | United States | $0.465B | 7.70 |
Biote (BTMD) | United States | $0.440B | 4.18 |
ZimVie (ZIMV) | United States | $0.431B | 26.53 |
Surmodics (SRDX) | United States | $0.402B | 43.40 |
Zynex (ZYXI) | United States | $0.397B | 45.74 |
Viemed Healthcare (VMD) | United States | $0.352B | 34.96 |
Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
Cerus (CERS) | United States | $0.315B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.253B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.247B | 14.91 |
TriSalus Life Sciences (TLSI) | United States | $0.245B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.230B | 0.00 |
Omeros (OMER) | United States | $0.218B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.199B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.182B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.173B | 0.00 |
High Tide (HITI) | Canada | $0.155B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.143B | 0.00 |
Fonar (FONR) | United States | $0.137B | 11.80 |
InterCure (INCR) | Israel | $0.116B | 19.61 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.110B | 0.00 |
FitLife Brands (FTLF) | United States | $0.107B | 20.86 |
Safety Shot (SHOT) | United States | $0.100B | 0.00 |
MariMed (MRMD) | United States | $0.098B | 0.00 |
Brainsway (BWAY) | Israel | $0.091B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.088B | 0.00 |
Veru (VERU) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.083B | 45.50 |
Zevia PBC (ZVIA) | United States | $0.070B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.27 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.047B | 0.00 |
Bright Green (BGXX) | United States | $0.045B | 0.00 |
Apyx Medical (APYX) | United States | $0.044B | 0.00 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.035B | 13.52 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |